Abstract
Objectives:
Eradication of Aggregatibacter actinomycetemcomitans (A. actionmycetemcomitans), as an opportunistic periodontopathogen, and inhibition of its virulence factor expression require a new adjunctive therapeutic method. In this study, we accessed the expression level of rcpA gene, as a virulence factor associated with A. actinomycetemcomitans biofilm formation, following treatment by antimicrobial photodynamic therapy (aPDT) using indocyanine green (ICG) doped with chitosan nanoparticles (CS-NPs@ICG).
Materials and Methods:
CS-NPs@ICG was synthesized and examined using scanning electron microscopy (SEM). A. actinomycetemcomitans ATCC 33384 strain was treated with CS-NPs@ICG, as a photosensitizer, which was excited with a diode laser at the wavelength of 810 nm with the energy density of 31.2 J/cm2. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to determine the changes in rcpA gene expression level.
Results:
Synthetized CS-NPs@ICG was confirmed via SEM. The results revealed that CS-NPs@ICG-mediated aPDT could significantly decrease rcpA gene expression to 13.2-fold (P<0.05). There was a remarkable difference between aPDT using CS-NPs@ICG and ICG (P<0.05). The diode laser, ICG, and CS-NPs@ICG were unable to significantly downregulate rcpA gene expression (P>0.05).
Conclusion:
aPDT with CS-NPs@ICG leads to a decrease of the virulence factor of A. actinomycetemcomitans and can be used as an adjunct to routine treatments for successful periodontal therapy in vivo.
Keywords: Actinobacillus actinomycetemcomitans, Gene Expression, Biofilm, Indocyanine Green
INTRODUCTION
Periodontal infections have polymicrobial etiology where multiple microorganism species are present in a periodontal lesion [1]. Numerous studies have considered Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans) as an important etiological microorganism involved in periodontitis [1–4]. This microorganism has several virulence factors including fimbriae, which are one of the important factors in the initial adhesion of A. actinomycetemcomitans. Rough-colony protein A (RcpA), which is found tandemly located downstream of the fimbriae, appears to play a critical role in the colonization of A. actinomycetemcomitans and in the formation of biofilms [3].
Traditional methods for periodontal therapy, including scaling and root planing or surgical procedures, as well as antibiotic therapy as an adjunct to the standard periodontal treatment regime, are unable to completely eliminate microorganisms [4]. Recently, antimicrobial photodynamic therapy (aPDT) has been considered as a non-invasive therapeutic approach, which allows for selective targeting of periodontal pathogens [5]. During aPDT, a photosensitizing agent, called a photosensitizer, is used with visible light at an appropriate wavelength. The photosensitizer is exited through exposure to the light and can release reactive oxygen species (ROS) in the presence of oxygen. ROS, such as superoxide, hydroxyl radicals, and hydrogen peroxide (H2O2), is harmful to cell membrane integrity and can cause biological death [6]. Although indocyanine green (ICG) is a photosensitizer with high in-vitro efficacy against oral microorganisms [7], it is unstable in aqueous solutions; this problem has been overcome by doping with nano-sized carriers [8]. Based on previous studies, chitosan nanoparticle (CSNP), as a cationic aminopolysaccharide and water-soluble polymer, has ideal properties for delivery of photosensitizers during aPDT [9]. To the best of our knowledge, there are no data on the effects of aPDT with ICG doped with CS-NPs (CS-NPs@ICG). Herein, we hypothesized that CS-NPs@ICG, as a photosensitizer, may have a significant effect on rspA genes expression of A. actinomycetemcomitans during aPDT.
MATERIALS AND METHODS
Study design:
To evaluate the effect of CS-NPs@ICG-mediated aPDT on gene expression of A. actinomycetemcomitans, the samples were allocated to the following groups:
ICG group
CS-NPs@ICG group
Diode laser group
ICG + Diode laser group
CS-NPs@ICG + Diode laser group
Control group
Preparation of CS-NPs@ICG:
According to the study by Govindarajan et al [10], CS-NPs were synthesized. In short, 50 mg of CS powder (Acros Organics; Fisher Scientific UK Ltd., Fair Lawn, UK) was dissolved in 50 ml of deionized distilled water. 1% acetic acid solution (Merck KGaA, Darmstadt, Germany) was then added dropwise under magnetic stirring process to create a homogeneous CS solution. Then, 2.0 mg/ml of ICG (Santa Cruz Biotechnology Co., Ltd; Shanghai, China) was added and mixed at 1000 rpm (revolutions per minute) for 10 minutes using a magnetic mixer. This mixture was centrifuged at 10,000 rpm (Eppendorf, Germany) for 30 minutes. The collected sediment CS-NPs@ICG was lyophilized and used for further experiments. The morphological analysis of CS-NPs@ICG was performed using scanning electron microscopy (SEM).
Bacterial strain and growth conditions:
A. actinomycetemcomitans ATCC 33384 strain (ETH Zurich, Switzerland) was cultured in brain heart infusion (BHI) broth (Merck KGaA, Darmstadt, Germany) containing 5 g/l of yeast extract (Merck KGaA, Darmstadt, Germany), 5 mg/l of hemin (Sigma-Aldrich Co., Ltd., Dorset, UK), and 1 mg/l of menadione (Sigma-Aldrich Co., Ltd., Dorset, UK) at 37°C in a microaerophilic atmosphere to adjust the cell density to 1.5×108 cells/ml.
Effect of aPDT using CS-NPs@ICG on biofilm formation-related gene expression of A. actinomycetemcomitans:
The wells of a 96-well round bottomed sterile polystyrene microplate (TPP; Trasadingen, Switzerland) were filled with 100 μl of A. actinomycetemcomitans suspension at the concentration of 1.5×108 colony-forming units (CFU)/ml. In groups A and B, 100 μl of ICG and 100 μl of CS-NPs@ICG were added to the wells, respectively. The microplate was incubated in the dark at room temperature for 5 minutes in a microaerophilic atmosphere. In group C, A. actinomycetemcomitans suspensions were exposed to DenLase diode laser therapy system (China Daheng Group, Inc., Beijing, China) irradiation at the wavelength of 810 nm with an output power of 250 mW and the energy density of 31.2 J/cm2. The output power of the diode laser was measured by a power meter (Laser Point s.r.l., Milano, Italy). The probe of the laser was fixed at 1 mm and 3 mm above the top surfaces of the microplate and the bacterial suspension, respectively, by a microphone stand (Fig. 1).
Fig. 1.

Laser irradiation of the surface of microplate wells during the treatment of bacteria with antimicrobial photodynamic therapy (aPDT).
The diameter of the irradiated area was the same as the diameter of the laser probe (6.39 mm). Groups D and E were treated with ICG and CS-NPs@ICG, respectively, similar to groups A and B. Then, the wells were exposed to the diode laser, similar to group C. A. actinomycetemcomitans suspension without any treatment (photosensitizers and light) served as a control group.
Preparation of total RNA and complementary DNA (cDNA) synthesis of treated A. actinomycetemcomitans:
The contents of each group in microplate wells were collected separately in sterile tubes. Total RNAs were extracted from all treated and untreated (control) A. actinomycetemcomitans samples using Geneall Hybrid-R™ RNA purification kit (Geneall Biotechnology Co., Ltd., Seoul, South Korea), according to the manufacturer's recommendations. The total RNA samples were treated with DNase I (Thermo Fisher Scientific, Darmstadt, Germany) after assessment with NanoDrop spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). Before reverse transcription, RNA samples were treated with DNase I to digest genomic DNAs. The RNA was used as a template to synthesize the primary cDNA chain by reverse transcription with a First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer's instructions.
Quantitative real-time polymerase chain reaction (qRT-PCR) assay:
The resulting cDNAs were used for the quantification of virulence gene mRNA levels by qRT-PCR with LightCycler® 96 Real-Time PCR System (Roche Applied Science, Mannheim, Germany). All primers utilized in this study were designed using the Primer 3 Plus web tool http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi/). The PCR primer sequences were rcpA-F, 5′-TGGGCATTAACTGGAGCCAC-3′; rcpA-R, 5′-ATCCACCTCCGAAACCGAAG-3′; 16S rRNA-F, 5′- AAGCACCGGCTAACTCCGT -3′; 16S rRNAR, 5′- TTCCGATTAACGCTCGCAC -3′. The 20-μl reaction volume contained 10 μl of SYBR Premix Ex Taq II (Takara Bio Inc., Kyoto, Japan) under the following conditions: 95°C for 5 minutes, amplification for 35 cycles with denaturation at 95°C for 15 seconds, annealing at 59°C for 30 seconds, and extension at 72°C for 30 seconds. The specificity of the primers was evaluated using melt curves.
Statistical analysis:
Statistical analysis was performed using one-way repeated-measures analysis of variance (ANOVA) and Bonferroni post-hoc test. The mRNA expression levels were shown as n-fold differences relative to the calibrator. Changes in expression levels of the target gene were interpreted as significant if the variation was >2-fold.
RESULTS
SEM experiment:
As shown in Figure 2, the CS-NPs@ICGs are nano-sized particles, approximately 60–100 nm in diameter, with uniform shapes.
Fig. 2.

Scanning electron microscopic image of synthesized indocyanine green doped with chitosan nanoparticle (CS-NPs@ICG)
Effects of aPDT using CS-NPs@ICG on rcpA gene expression:
The melting curve profiles generated by real-time amplification confirmed the non-specific PCR product. According to Figure 3, the transcription of rcpA gene decreased by 6.4- and 13.2-fold with aPDT using ICG and CS-NP@ICG, respectively (P<0.05). In contrast, there was no significant change in the expression of data obtained from the results of the analysis of rcpA gene in the diode laser, ICG, and CS-NPs@ICG groups alone (0.7-, 1.0-, and 1.7-fold, respectively, P>0.05; Fig. 3). On the other hand, there was a significant difference between aPDT groups; CS-NPs@ICG-aPDT could downregulate the expression of rcpA gene by 6.8-fold compared to ICG-aPDT (P<0.05).
Fig. 3.

Effect of antimicrobial photodynamic therapy (aPDT) on gene expression of Aggregatibacter actinomycetemcomitans; *Significant variation >2-fold.
DISCUSSION
Recently, aPDT has attracted a lot of attention among clinicians for treatment of microbial pathogenic biofilms [11,12]. A. actionmycetemcomitans is considered as the main agent in periodontitis and periimplantitis [1]. A. actinomycetemcomitans has numerous virulence factors that are associated with colonization, biofilm formation, and invasion of host tissue, such as fimbriae, adherence proteins, biofilm polysaccharides, leukotoxin, chemotactic inhibitors, cytolethal distending toxin, and bacteriocins [13]. Fimbria, as the virulence factor that attaches to the host cells via channels formed by RcpA, is involved in biofilm formation [14]. Therefore, prevention of A. actinomycetemcomitans dispersion from the oral cavity and initiation of systemic infections has led to a new therapeutic approach.
Evidence from several systematic reviews and clinical trials suggests that aPDT is a useful adjunct to mechanical debridement for nonsurgical management of chronic and aggressive periodontitis and periimplantitis [15–18]. In order for aPDT to be efficient, the use of an appropriate photosensitizer is an essential factor for damages experienced by the cytoplasmic membrane and DNA. Therefore, an ideal photosensitizer must have the following properties: availability in pure form, high singlet oxygen quantum yield, strong absorption in the visible spectrum, stability and solubility in aqueous media, easy delivery to the target site, and non-toxicity [19]. In this regard, ICG would be an acceptable candidate as a photosensitizer for aPDT. ICG has a very interesting photochemical property with strong absorption at 700–800 nm and optimal peak absorption at 800–810 nm. Nagahara et al [20] stated that ICG is a potential photosensitizer for aPDT to achieve clearance of periodontal pathogens. Despite the potential effects of ICG in inhibition of proliferation and formation of microbial biofilm, the disadvantages of ICG can reduce its efficiency. The major disadvantage of using ICG in PDT is the aqueous instability, photodegradation, and thermal degradation in vitro and in vivo [21]. ICG undergoes physicochemical variations such as aggregation and irreversible degradation in aqueous solutions, which can lead to discoloration, decreased light absorption, decreased fluorescence, and a shift in the wavelength of absorption [22,23].
In recent years, polymeric nanoparticles, such as CS-NPs, have provided efficient aqueous, photo, and thermal stability for ICG [24]. CS is both biodegradable and biocompatible and widely used in various pharmaceutical nano-formulations [25]. Therefore, in this study, we made a nano-carrier by doping ICG to a natural polymer (low molecular-weight CS). These facts encouraged us to evaluate the efficacy of aPDT using CS-NPs@ICG against biofilm formation-related gene expression of A. actinomycetemcomitans.
As previously mentioned, quantitative data showed that rcpA gene in A. actinomycetemcomitans was significantly decreased following aPDT using CS-NPs@ICG. In contrast, diode laser alone without previous incubation with CS-NPs@ICG could not lead to a significant reduction of A. actinomycetemcomitans gene expression.
The results of this study are consistent with the study conducted by Pourhajibagher et al [26]. They investigated the potential of aPDT using curcumin (CUR) against A. actinomycetemcomitans. The results of their study showed that the respective dye used in combination with a light source resulted in a substantial reduction of the number of surviving A. actinomycetemcomitans or of the growing A. actinomycetemcomitans compared to the control groups [26]. Several studies have been performed by Pourhajibagher et al [26–28] on gene expression of A. actinomycetemcomitans rcpA based on aPDT with different photosensitizers. The results of their investigations showed that rcpA gene expression was downregulated by 4-, 6-, and 8.5-fold following treatment by methylene blue (MB), ICG, and CUR, respectively [26–28]. The findings of these studies are consistent with our results.
It is noteworthy that the main finding of this study, compared to other studies, is that aPDT using CS-NPs/ICG could reduce the expression of biofilm formation-related gene far more than ICG. Despite all the valuable findings of this study, additional in situ and in vivo studies are needed for definitive establishment of an effective protocol for periodontitis and periimplantitis treatment.
CONCLUSION
As revealed by the results of this study, aPDT treatment using CS-NPs@ICG significantly downregulated the expression of rcpA gene which is involved in biofilm formation of A. actinomycetemcomitans. Thus, aPDT using CS-NPs@ICG, described herein, may demonstrate a versatile method to control periopathogens.
ACKNOWLEDGMENTS
This research has been financially supported by Tehran University of Medical Sciences (Grant No# 96-01-30-34552).
Footnotes
CONFLICT OF INTEREST STATEMENT
None declared.
REFERENCES
- 1.Torrungruang K, Jitpakdeebordin S, Charatkulangkun O, Gleebbua Y. Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, and Treponema denticola / Prevotella intermedia Co-Infection Are Associated with Severe Periodontitis in a Thai Population. PLoS One. 2015. August 27;10(8):e0136646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Arenas Rodrigues VA, de Avila ED, Nakano V, Avila-Campos MJ. Qualitative, quantitative and genotypic evaluation of Aggregatibacter actinomycetemcomitans and Fusobacterium nucleatum isolated from individuals with different periodontal clinical conditions. Anaerobe. 2018. August;52:50–58. [DOI] [PubMed] [Google Scholar]
- 3.Mahalakshmi K, Krishnan P, Chandrasekaran SC. Detection of Aggregatibacter actinomycetemcomitans leukotoxin and fimbria-associated protein gene genotypes among periodontitis patients and healthy controls: A case-control study. Dent Res J (Isfahan). 2018. May-Jun;15(3):185–190. [PMC free article] [PubMed] [Google Scholar]
- 4.Deas DE, Moritz AJ, Sagun RS, Jr, Gruwell SF, Powell CA. Scaling and root planing vs. conservative surgery in the treatment of chronic periodontitis. Periodontol 2000. 2016. June;71(1):128–39. [DOI] [PubMed] [Google Scholar]
- 5.Saitawee D, Teerakapong A, Morales NP, Jitprasertwong P, Hormdee D. Photodynamic therapy of Curcuma longa extract stimulated with blue light against Aggregatibacter actinomycetemcomitans. Photodiagnosis Photodyn Ther. 2018. June;22:101–105. [DOI] [PubMed] [Google Scholar]
- 6.Azizi A, Mousavian S, Taheri S, Lawaf S, Gonoudi E, Rahimi A. Comparison of the antimicrobial efficacy of photodynamic therapy with two mediators against Lactobacillus acidophilus in vitro. Photodiagnosis Photodyn Ther. 2018. March;21:357–362. [DOI] [PubMed] [Google Scholar]
- 7.Ormond AB, Freeman HS. Dye Sensitizers for Photodynamic Therapy. Materials (Basel). 2013. March 6;6(3):817–840. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Sasaki Y, Hayashi JI, Fujimura T, Iwamura Y, Yamamoto G, Nishida E, et al. New Irradiation Method with Indocyanine Green-Loaded Nanospheres for Inactivating Periodontal Pathogens. Int J Mol Sci. 2017. January 13;18(1). pii: E154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Chen R, Wang X, Yao X, Zheng X, Wang J, Jiang X. Near-IR-triggered photothermal/photodynamic dual-modality therapy system via chitosan hybrid nanospheres. Biomaterials. 2013. November;34(33):8314–22. [DOI] [PubMed] [Google Scholar]
- 10.Govindarajan C, Ramasubramaniam S, Gomathi T, Narmadha Devi A, Sudha PN. Sorption studies of Cr (VI) from aqueous solution using nanochitosan-carboxymethyl cellulose blend. Arch Appl Sci Res. 2011. January;3(4):127–138. [Google Scholar]
- 11.Hu X, Huang YY, Wang Y, Wang X, Hamblin MR. Antimicrobial Photodynamic Therapy to Control Clinically Relevant Biofilm Infections. Front Microbiol. 2018. June 27;9:1299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Cieplik F, Tabenski L, Buchalla W, Maisch T. Antimicrobial photodynamic therapy for inactivation of biofilms formed by oral key pathogens. Front Microbiol. 2014. August 12;5:405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Smith KP, Ruiz T, Mintz KP. Inner-membrane protein MorC is involved in fimbriae production and biofilm formation in Aggregatibacter actinomycetemcomitans. Microbiology. 2016. March;162(3):513–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Benso B. Virulence factors associated with Aggregatibacter actinomycetemcomitans and their role in promoting periodontal diseases. Virulence. 2017;8(2):111–114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Smiley CJ, Tracy SL, Abt E, Michalowicz BS, John MT, Gunsolley J, et al. Systematic review and meta-analysis on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts. J Am Dent Assoc. 2015. July;146(7):508–24.e5. [DOI] [PubMed] [Google Scholar]
- 16.Azarpazhooh A, Shah PS, Tenenbaum HC, Goldberg MB. The effect of photodynamic therapy for periodontitis: A systematic review and meta-analysis. J Periodontol. 2010. January;81(1):4–14. [DOI] [PubMed] [Google Scholar]
- 17.Ahad A, Lamba AK, Faraz F, Tandon S, Chawla K, Yadav N. Effect of antimicrobial photodynamic therapy as an adjunct to nonsurgical treatment of deep periodontal pockets: a clinical study. J Lasers Med Sci. 2016. Autumn;7(4):220–226. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Sgolastra F, Petrucci A, Severino M, Graziani F, Gatto R, Monaco A. Adjunctive photodynamic therapy to non-surgical treatment of chronic periodontitis: a systematic review and meta-analysis. J Clin Periodontol. 2013. May;40(5):514–26. [DOI] [PubMed] [Google Scholar]
- 19.Abrahamse H, Hamblin MR. New photosensitizers for photodynamic therapy. Biochem J. 2016. February 15;473(4):347–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Nagahara A, Mitani A, Fukuda M, Yamamoto H, Tahara K, Morita I, et al. Antimicrobial photodynamic therapy using a diode laser with a potential new photosensitizer, indocyanine green-loaded nanospheres, may be effective for the clearance of Porphyromonas gingivalis. J Periodontal Res. 2013. October;48(5):591–9. [DOI] [PubMed] [Google Scholar]
- 21.Gomes AJ, Lunardi LO, Marchetti JM, Lunardi CN, Tedesco AC. Indocyanine green nanoparticles useful for photomedicine. Photomed Laser Surg. 2006. August;24(4):514–21. [DOI] [PubMed] [Google Scholar]
- 22.Saxena V, Sadoqi M, Shao J. Degradation kinetics of indocyanine green in aqueous solution. J Pharm Sci. 2003. October;92(10):2090–7. [DOI] [PubMed] [Google Scholar]
- 23.Holzer W, Mauerer M, Penzkofer A, Szeimies RM, Abels C, Landthaler M, et al. Photostability and thermal stability of indocyanine green. J Photochem Photobiol B. 1998. December;47(2–3):155–64. [DOI] [PubMed] [Google Scholar]
- 24.Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003. February 24;55(3):329–47. [DOI] [PubMed] [Google Scholar]
- 25.Naqvi S, Mohiyuddin S, Gopinath P. Niclosamide loaded biodegradable chitosan nanocargoes: an in vitro study for potential application in cancer therapy. R Soc Open Sci. 2017. November;4(11):170611. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Pourhajibagher M, Chiniforush N, Monzavi A, Barikani HR, Monzavi MM, Sobhani S, et al. Inhibitory effects of antimicrobial photodynamic therapy with Curcumin on biofilm-associated gene expression profile of Aggregatibacter actinomycetemcomitans. J Dent (Tehran). 2018. May;15(3):169–177. [PMC free article] [PubMed] [Google Scholar]
- 27.Pourhajibagher M, Monzavi A, Chiniforush N, Monzavi MM, Sobhani S, Shahabi S, et al. Real-time quantitative reverse transcription-PCR analysis of expression stability of Aggregatibacter actinomycetemcomitans fimbria-associated gene in response to photodynamic therapy. Photodiagnosis Photodyn Ther. 2017. June;18:78–82. [DOI] [PubMed] [Google Scholar]
- 28.Pourhajibagher M, Chiniforush N, Shahabi S, Sobhani S, Monzavi MM, Monzavi A, et al. Monitoring gene expression of rcpA from Aggregatibacter actinomycetemcomitans versus antimicrobial photodynamic therapy by relative quantitative real-time PCR. Photodiagnosis Photodyn Ther. 2017. September;19:51–55. [DOI] [PubMed] [Google Scholar]
